Javier Rodriguez Davita Inc. (DVA) insider trading activity

Javier Rodriguez is Chief Executive Officer of DAVITA INC.. Currently has a direct ownership of 897,716 shares of DVA, which is worth approximately $147 Million. The most recent transaction as insider was on Jun 06, 2022, when has been sold 54,111 shares (Common Stock) at a price of $96.7 per share, resulting in proceeds of $5,232,534. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 898K

27.53% 3M change

169.34% 12M change

Total Value Held $147 Million

Javier Rodriguez Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2022	SELL Sale (or disposition) back to the issuer	$5,232,534 $96.7 p/Share	54,111 Reduced 14.2%	326,948 Common Stock
Jun 06 2022	SELL Payment of exercise price or tax liability	$1,095,224 $96.7 p/Share	11,326 Reduced 3.46%	315,622 Common Stock
Jun 06 2022	BUY Exercise of conversion of derivative security	$5,232,442 $65.48 p/Share	79,909 Added 17.34%	381,059 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$7,820,008 $100.05 p/Share	78,161 Reduced 20.61%	301,150 Common Stock
May 12 2022	BUY Grant, award, or other acquisition	-	24,890 Added 6.16%	379,311 Common Stock
Apr 22 2022	BUY Grant, award, or other acquisition	-	109,478 Added 23.6%	354,421 Common Stock
May 15 2021	SELL Payment of exercise price or tax liability	$3,597,010 $125.41 p/Share	28,682 Reduced 10.48%	244,943 Common Stock
May 05 2021	SELL Sale (or disposition) back to the issuer	$9,358,953 $123.36 p/Share	75,867 Reduced 19.08%	321,849 Common Stock
May 05 2021	SELL Open market or private sale	$3,306,418 $122.22 p/Share	27,053 Reduced 9.0%	273,625 Common Stock
May 05 2021	SELL Payment of exercise price or tax liability	$2,611,655 $123.36 p/Share	21,171 Reduced 6.58%	300,678 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$9,358,943 $75.42 p/Share	124,091 Added 23.78%	397,716 Common Stock
Apr 20 2021	BUY Grant, award, or other acquisition	-	6,071 Added 2.17%	273,625 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	50,438 Added 15.86%	267,554 Common Stock

Also insider at

GILD

GILEAD SCIENCES, INC. Healthcare

Director